Breaking News

Tweet TWEET

DS Healthcare Group Reports Third Quarter 2013 Results

DS Healthcare Group Reports Third Quarter 2013 Results

Record net revenues of $10,600,000 for the nine months ended September 30,
2013

Pompano Beach, Nov. 15, 2013 (GLOBE NEWSWIRE) -- DS Healthcare Group,
Inc.(NASDAQ:DSKX), a leading developer of personal care products, today
announced financial results for the three and nine months ended September 30,
2013.

Net revenues increased 22% in the first nine months of 2013 to $10,593,035
over net revenues of $8,672,634 in the same period of 2012. Revenue growth was
primarily driven by the acquisition of the Company's Mexican subsidiary. Gross
profits for the nine months ended September 30, 2013 were $5,138,195 as
compared to $4,292,464 in the same period of 2012. Net loss attributable to
shareholders during the nine months ended September 30, 2013 was $(2,268,463)
or $(0.18) per basic and diluted share, as compared to $(848,786) or $(0.08)
per basic and diluted share in the same period of 2012. Increased loss was in
part attributed to the rapid expansion in Mexico, larger operational
infrastructure and non-cash items.

Net revenues for the third quarter of 2013 were $3,200,189, a 0.3% increase
from net revenues of $3,190,390 in the third quarter of 2012. Lower revenues
in the U.S. due to the Company's new policies related to extending credit to
new and existing customers, preventing the Company from shipping some goods on
its schedule. Gross profits in the third quarter were $1,762,426, as compared
to $1,791,383 in the third quarter of fiscal 2012. Net loss attributable to
shareholders in the third quarter of 2013 was $(1,053,406) or $(0.08) per
basic and diluted share as compared to $(40,364) or $(0.00) per basic and
diluted share in the third quarter of 2012.

The Company reported total current assets of $5,388,823 and total
shareholders' equity of $3,548,732 on September 30, 2013.

"In the first nine months of 2013 our top line revenues hit a new record. In
addition to continuing our marketing and sales efforts for our current product
lines, we are expanding our distribution channels both domestically and
internationally," stated DS Healthcare President and CEO Daniel Khesin.

"Third quarter initiatives included launching our e-commerce site in Brazil
and signing a distributor in China. Our R&D efforts have led to innovations
that now position us to grow beyond the over-the-counter market in hair care
and eventually into the highly lucrative prescription hair loss treatment
market. In October we filed a patent application with the United States Patent
and Trademark Office for our invention, 'Compositions and Methods for
Treatment of Hair Loss'. We look forward to a strong finish for 2013," Khesin
concluded.

About DS Healthcare Group

DS Healthcare Group Inc. leads in the development and distribution of topical
therapies for personal care, including what management believes is the world's
most effective topical treatment for hair loss. Its products are sold through
a network of salons, pharmacies, online retailers, specialty retailers and
select department stores. Its brands include DS
Laboratories(www.DSLaboratories.com), Sigma Skin (www.(www.SigmaSkin.com),
Polaris Research Laboratories(www.PolarisResearchLabs.com) The Pure
Guild(www.ThePureGuild.com) and Nutra Origin(www.NutraOrigin.com)

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press
release are forward-looking and made pursuant to the Safe Harbor provisions of
the Private Securities Litigation Reform Act of 1995. "Forward-looking
statements" describe future expectations, plans, results, or strategies, and
are generally preceded by words such as "future," "plan" or "planned,"
"expects," or "projected." These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many of which
are beyond the company's control that may cause actual results to differ
materially from stated expectations. These risk factors include, among others,
limited operating history, difficulty in developing and marketing products,
intense competition, and additional risks factors as discussed in reports
filed by the company with the Securities and Exchange Commission, which are
available at http://www.sec.gov.

CONTACT: Contact:
        
         Laurel Moody
         Corporate Profile
         1.646.810.0608

DS Healthcare Group,Inc.